Literature DB >> 19353688

Pure monosomy and pure trisomy of 13q21.2-31.1 consequent to a familial insertional translocation: exclusion of PCDH9 as the responsible gene for autosomal dominant auditory neuropathy (AUNA1).

Francesca R Grati1, Marci M Lesperance, Simona De Toffol, Sara Chinetti, Angelo Selicorni, Sarah Emery, Beatrice Grimi, Francesca Dulcetti, Barbara Malvestiti, Joseph Taylor, Silvia Milani, Anna M Ruggeri, Federico Maggi, Giuseppe Simoni.   

Abstract

Insertional translocations (IT) are rare structural rearrangements. Offspring of IT balanced carriers are at high risk to have either pure partial trisomy or monosomy for the inserted segment as manifested by "pure" phenotypes. We describe an IT between chromosomes 3 and 13 segregating in a three-generation pedigree. Short tandem repeat (STR) segregation analysis and array-comparative genomic hybridization were used to define the IT as a 25.1 Mb segment spanning 13q21.2-q31.1. The phenotype of pure monosomy included deafness, duodenal stenosis, developmental and growth delay, vertebral anomalies, and facial dysmorphisms; the trisomy was manifested by only minor dysmorphisms. As the AUNA1 deafness locus on 13q14-21 overlaps the IT in the PCDH9 (protocadherin-9) gene region, PCDH9 was investigated as a candidate gene for deafness in both families. Genotyping of STRs and single nucleotide polymorphisms defined the AUNA1 breakpoint as 35 kb 5' to PCDH9, with a 2.4 Mb area of overlap with the IT. DNA sequencing of coding regions in the AUNA1 family and in the retained homologue chromosome in the monosomic patient revealed no mutations. We conclude that AUNA1 deafness does not share a common etiology with deafness associated with monosomy 13q21.2-q31.3; deafness may result from monosomy of PCHD9 or another gene in the IT, as has been demonstrated in contiguous gene deletion syndromes. Precise characterization of the breakpoints of the translocated region is useful to identify which genes may be contributing to the phenotype, either through haploinsufficiency or extra dosage effects, in order to define genotype-phenotype correlations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353688     DOI: 10.1002/ajmg.a.32754

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila.

Authors:  Cynthia J Schoen; Sarah B Emery; Marc C Thorne; Hima R Ammana; Elzbieta Sliwerska; Jameson Arnett; Michael Hortsch; Frances Hannan; Margit Burmeister; Marci M Lesperance
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 2.  Non-clustered protocadherin.

Authors:  Soo-Young Kim; Shin Yasuda; Hidekazu Tanaka; Kanato Yamagata; Hyun Kim
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 3.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

Review 4.  Nerve maintenance and regeneration in the damaged cochlea.

Authors:  Seiji B Shibata; Cameron L Budenz; Sara A Bowling; Bryan E Pfingst; Yehoash Raphael
Journal:  Hear Res       Date:  2011-05-10       Impact factor: 3.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.